Jazz Pharmaceuticals plc 4

EVP and Chief Commercial Officer Samantha Pearce had 780 Jazz Pharmaceuticals ordinary shares withheld for taxes upon RSU vesting, leaving her with 47,131 shares owned directly.

On August 5, 2026, Samantha Pearce, EVP and Chief Commercial Officer of Jazz Pharmaceuticals plc, had 780 ordinary shares withheld by the company at an implied price of approximately $261.62 per share, totaling about $204,064, to satisfy tax obligations arising from the vesting of previously granted restricted stock units; following this routine tax-withholding transaction, she beneficially owned 47,131 ordinary shares directly.

Filing Facts

CIK

1232524

Ticker

JAZZ

Form

4

Source Type

fda

Accession

0001805688-26-000014

Alert Tier

5